Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Parkinsonism in multiple sclerosis patients: A casual or causal association?
The pathogenic role of the inflammasome in neurodegenerative diseases.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Fingolimod after natalizumab and the risk of short-term relapse.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
Movement disorders in multiple sclerosis.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
Activated microglia enhance neurogenesis via trypsinogen secretion.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Molecular mimicry in the etiology of autoimmune diseases.
Teva targets $4 billion lupus market with laquinimod study
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Optical Coherence Tomography for the Radiologist.
Pages
« first
‹ previous
…
227
228
229
230
231
232
233
234
235
…
next ›
last »